Xcout Intel
Latent Labs Technologies, Inc.
Latent Labs Technologies operates as a frontier artificial intelligence laboratory that builds generative models for molecular biology. The company provides AI-driven tools and agents—such as Latent-Y, Latent-X2, and Latent-X—to help researchers and partners design drugs, create antibodies, optimize enzymes, and advance genetic engineering.
Subscribe to see Latent Labs Technologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Latent Labs Technologies, Inc. at a glance
Latent Labs Technologies, Inc. is an artificial intelligence & biotechnology company headquartered in United States. It has raised at least $49M across the 2 funding rounds on record. Its most recent funding round raised $39.9M in December 2024. Xcout tracks 5 named people at Latent Labs Technologies, Inc., including Simon Kohl (Chief Executive Officer).
Latent Labs Technologies, Inc. leadership
- Simon KohlChief Executive Officer
- Simon KohlFounder & CEO
- Simon KohlExecutive Officer
- John CassidyDirector
- Tony KulesaDirector
Latent Labs Technologies, Inc. funding rounds
At least $49M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $39.9M | — | |
| SEC Form D filing | $9.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Latent Labs Technologies, Inc. competitors
A few of Latent Labs Technologies, Inc.'s closest competitors — see the full list of competitors and alternatives →
Astromech AI Corp. is developing an autonomous biological intelligence system, termed the Large Life Model, which integrates deep learning with evolutionary biology. The platform is designed to process multi-species transcriptomic and genomic data to assist researchers in therapeutic development, trait optimization, and systems biology.
Inceptive is a data-driven lab focused on AI medicines, creating tools for the rational design of novel biomolecules and biological software. The company has offices in Palo Alto, Berlin, and Zurich, and is pioneering the next generation of AI-driven medical advancements.
DenovAI Biotech Ltd is an Israeli biotechnology startup founded in 2023 and operated through the AION Labs venture studio in Rehovot. The company develops a generative AI and physics platform focused on the de novo design of novel proteins and therapeutic biologics.
Pepticom operates an artificial intelligence-driven drug discovery platform focused on designing and optimizing novel therapeutic peptides. The company utilizes reinforcement learning, generative AI, and computational algorithms to develop drug candidates for both internal programs and industry collaborations.
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
TenAces Biosciences is an Israel-based biopharmaceutical company and AION Labs startup that develops molecular glue therapeutics. The company utilizes machine learning and an AI platform to identify protein interactions and discover new molecular glue therapies.
Get Latent Labs Technologies, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Latent Labs Technologies, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Latent Labs Technologies, Inc. in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access